Reactive oxygen intermediates in TNF signaling

Molecular Immunology

Volumn 39, Issue 9, 2002, Pages 509-517

  Garg, Amit K ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AP 1; Apoptosis; JNK; MAPK; NF B; ROI; TNF

Indexed keywords

CASPASE; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR;

APOPTOSIS; CELL DIFFERENTIATION; CELL SURVIVAL; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036889641     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00207-9     Document Type: Review

References (101)

1. Aggarwal B.B. Apoptosis and nuclear factor-κB: a tale of association and dissociation. Biochem. Pharmacol. 60(8):2000;1033-1039.
2. Aggarwal B.B., Natarajan K. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Net. 7(2):1996;93-124.
3. Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. U.S.A. 91(24):1994;11527-11531.
4. Arch R.H., Thompson C.B. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol. 18(1):1998;558-565.
5. Arch R.H., Gedrich R.W., Thompson C.B. Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adapter proteins that regulates life and death. Genes Dev. 12(18):1998;2821-2830.
6. Arch R.H., Thompson C.B. Lymphocyte survival - the struggle against death. Annu. Rev. Cell. Dev. Biol. 15:1999;113-140.
7. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281(5381):1998;1305-1308.
8. Baeuerle P.A., Baltimore D. NF-κB: ten years after. Cell. 87(1):1996;13-20.
9. Bakker T.R., Reed D., Renno T., Jongeneel C.V. Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int. J. Cancer. 80(2):1999;320-323.
10. Bauer M.K., Vogt M., Los M., Siegel J., Wesselborg S., Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J. Biol. Chem. 273(14):1998;8048-8055.
11. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science. 274(5288):1996. 782-784.
12. Beutler B. Cytokines and cancer cachexia. Hosp. Pract. (off ed.). 28(4):1993;45-52.
13. Boldin M.P., Varfolomeev E.E., Pancer Z., Mett I.L., Camonis J.H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270(14):1995;7795-7798.
14. 2 in NF-κB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem. 272(41):1997;25941-25950.
15. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18(11):1998;6353-6364.
16. Brekke O.L., Shalaby M.R., Sundan A., Espevik T., Bjerve K.S. Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. Cytokine. 4(4):1992;269-280.
17. Brennan P., O'Neill L.A. Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim. Biophys. Acta. 1260(2):1995;167-175.
18. Cai Z., Capoulade C., Moyret-Lalle C., Amor-Gueret M., Feunteun J., Larsen A.K., Paillerets B.B., Chouaib S. Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene. 15(23):1997;2817-2826.
19. Casano F.J., Rolando A.M., Mudgett J.S., Molineaux S.M. The structure and complete nucleotide sequence of the murine gene encoding interleukin-1 beta converting enzyme (ICE). Genomics. 20(3):1994;474-481.
20. Chandel N.S., Schumacker P.T., Arch R.H. Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J. Biol. Chem. 276(46):2001;42728-42736.
21. Chinnaiyan A.M., O'Rourke K., Tewari M., Dixit V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81(4):1995;505-512.
22. Chu Z.L., McKinsey T.A., Liu L., Gentry J.J., Malim M.H., Ballard D.W. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl. Acad. Sci. U.S.A. 94(19):1997;10057-10062.
23. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 274(5291):1996;1379-1383.
24. Das K.C., Lewis-Molock Y., White C.W. Activation of NF-κB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am. J. Physiol. 269(5 Pt 1):1995;L588-602.
25. De Vos K., Goossens V., Boone E., Vercammen D., Vancompernolle K., Vandenabeele P., Haegeman G., Fiers W., Grooten J. The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J. Biol. Chem. 273(16):1998;9673-9680.
26. Doi T.S., Marino M.W., Takahashi T., Yoshida T., Sakakura T., Old L.J., Obata Y. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 96(6):1999;2994-2999.
27. Fernandez-Checa J.C., Kaplowitz N., Garcia-Ruiz C., Colell A., Miranda M., Mari M., Ardite E., Morales A. GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 273(1 Pt 1):1997;G7-17.
28. Ferran C., Stroka D.M., Badrichani A.Z., Cooper J.T., Wrighton C.J., Soares M., Grey S.T., Bach F.H. A20 inhibits NF-κB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood. 91(7):1998;2249-2258.
29. Galter D., Mihm S., Droge W. Distinct effects of glutathione disulphide on the nuclear transcription factor κB and the activator protein-1. Eur. J. Biochem. 221(2):1994;639-648.
30. Garcia-Lloret M.I., Yui J., Winkler-Lowen B., Guilbert L.J. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J. Cell. Physiol. 167(2):1996;324-332.
31. Garcia-Ruiz C., Colell A., Morales A., Kaplowitz N., Fernandez-Checa J.C. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: studies with isolated mitochondria and rat hepatocytes. Mol. Pharmacol. 48(5):1995;825-834.
32. Gedrich R.W., Gilfillan M.C., Duckett C.S., Van Dongen J.L., Thompson C.B. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J. Biol. Chem. 271(22):1996;12852-12858.
33. Ginn-Pease M.E., Whisler R.L. Redox signals and NF-κB activation in T cells. Free Radic. Biol. Med. 25(3):1998;346-361.
34. Giri D.K., Aggarwal B.B. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J. Biol. Chem. 273(22):1998;14008-14014.
35. Goossens V., Grooten J., De Vos K., Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 92(18):1995;8115-8119.
36. Goossens V., Grooten J., Fiers W. The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J. Biol. Chem. 271(1):1996;192-196.
37. Gotoh Y., Cooper J.A. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J. Biol. Chem. 273(28):1998;17477-17482.
38. Higashi N., Yoshizuka N., Kobayashi Y. Phenotypic properties and cytokine production of skin-infiltrating cells obtained from guinea pig delayed-type hypersensitivity reaction sites. Cell. Immunol. 164(1):1995;28-35.
39. Higuchi M., Aggarwal B.B., Yeh E.T. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J. Clin. Invest. 99(7):1997;1751-1758.
40. Higuchi M., Proske R.J., Yeh E.T. Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene. 17(19):1998;2515-2524.
41. Hockenbery D.M., Oltvai Z.N., Yin X.M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75(2):1993;241-251.
42. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275(5296):1997;90-94.
43. 2. J. Clin. Invest. 89(3):1992;794-802.
44. Kane D.J., Sarafian T.A., Anton R., Hahn H., Gralla E.B., Valentine J.S., Ord T., Bredesen D.E. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 262(5137):1993;1274-1277.
45. Karin M., Liu Z., Zandi E. AP-1 function and regulation. Curr. Opin. Cell. Biol. 9(2):1997;240-246.
46. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270(28):1995;16483-16486.
47. Kinscherf R., Claus R., Wagner M., Gehrke C., Kamencic H., Hou D., Nauen O., Schmiedt W., Kovacs G., Pill J., Metz J., Deigner H.P. Apoptosis caused by oxidized LDL is manganese superoxide dismutase and p53 dependent. FASEB J. 12(6):1998;461-467.
48. Kothny-Wilkes G., Kulms D., Poppelmann B., Luger T.A., Kubin M., Schwarz T. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J. Biol. Chem. 273(44):1998;29247-29253.
49. La Rosa F.A., Pierce J.W., Sonenshein G.E. Differential regulation of the c-myc oncogene promoter by the NF-κB rel family of transcription factors. Mol. Cell. Biol. 14(2):1994;1039-1044.
50. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the IκB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88(2):1997;213-222.
51. Li J.J., Oberley L.W. Overexpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor alpha and/or hyperthermia. Cancer Res. 57(10):1997;1991-1998.
52. Licinio J., Wong M.L. Interleukin 1 beta and fever. Nat. Med. 2(12):1996;1314-1315.
53. Liu B., Andrieu-Abadie N., Levade T., Zhang P., Obeid L.M., Hannun Y.A. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J. Biol. Chem. 273(18):1998;11313-11320.
54. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104(4):2001;487-501.
55. Manna S.K., Haridas V., Aggarwal B.B. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-κB, activation protein-1, and c-Jun N-terminal kinase. J. Interferon Cytokine Res. 20(8):2000;725-735.
56. Manna S.K., Kuo M.T., Aggarwal B.B. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activator protein-1. Oncogene. 18(30):1999;4371-4382.
57. Manna S.K., Zhang H.J., Yan T., Oberley L.W., Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273(21):1998;13245-13254.
58. Mehlen P., Kretz-Remy C., Preville X., Arrigo A.P. Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J. 15(11):1996;2695-2706.
59. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12(5):1993;2005-2015.
60. Minn A.J., Swain R.E., Ma A., Thompson C.B. Recent progress on the regulation of apoptosis by Bcl-2 family members. Adv. Immunol. 70:1998;245-279.
61. Morales A., Garcia-Ruiz C., Miranda M., Mari M., Colell A., Ardite E., Fernandez-Checa J.C. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase. J. Biol. Chem. 272(48):1997;30371-30379.
62. Muller-Ladner U. Molecular and cellular interactions in rheumatoid synovium. Curr. Opin. Rheumatol. 8(3):1996;210-220.
63. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V.L., Agresti C., Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 273(47):1998;31262-31272.
64. Obrador E., Navarro J., Mompo J., Asensi M., Pellicer J.A., Estrela J.M. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem. J. 325(Pt 1):1997;183-189.
65. Pastorino J.G., Simbula G., Yamamoto K., Glascott P.A. Jr., Rothman R.J., Farber J.L. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271(47):1996;29792-29798.
66. Phelps D.T., Ferro T.J., Higgins P.J., Shankar R., Parker D.M., Johnson A. TNF-alpha induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am. J. Physiol. 269(4 Pt 1):1995;L551-559.
67. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., Bours V. Multiple redox regulation in NF-κB transcription factor activation. Biol. Chem. 378(11):1997;1237-1245.
68. Polunovsky V.A., Wendt C.H., Ingbar D.H., Peterson M.S., Bitterman P.B. Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp. Cell. Res. 214(2):1994;584-594.
69. Rath P.C., Aggarwal B.B. TNF-induced signaling in apoptosis. J. Clin. Immunol. 19(6):1999;350-364.
70. Rathmell J.C., Thompson C.B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17:1999;781-828.
71. Risberg B., Andreasson S., Eriksson E. Disseminated intravascular coagulation. Acta Anaesthesiol. Scand. Suppl. 95:1991;60-71.
72. Roederer M., Staal F.J., Raju P.A., Ela S.W., Herzenberg L.A., Herzenberg L.A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl. Acad. Sci. U.S.A. 87(12):1990;4884-4888.
73. Rothe M., Wong S.C., Henzel W.J., Goeddel D.V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78(4):1994;681-692.
74. Rothe M., Sarma V., Dixit V.M., Goeddel D.V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science. 269(5229):1995;1424-1427.
75. Rutka J.T., Giblin J.R., Berens M.E., Bar-Shiva E., Tokuda K., McCulloch J.R., Rosenblum M.L., Eessalu T.E., Aggarwal B.B., Bodell W.J. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int. J. Cancer. 41(4):1988;573-582.
76. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. U.S.A. 91(5):1994;1672-1676.
77. Schreck R., Grassmann R., Fleckenstein B., Baeuerle P.A. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I Tax protein. J. Virol. 66(11):1992a;6288-6293.
78. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175(5):1992b;1181-1194.
79. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10(8):1991;2247-2258.
80. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jacob W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267(8):1992;5317-5323.
81. Schulze-Osthoff K., Beyaert R., Vandevoorde V., Haegeman G., Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12(8):1993;3095-3104.
82. Sen C.K., Khanna S., Reznick A.Z., Roy S., Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced NF-κB activation in skeletal muscle-derived L6 cells. Biochem. Biophys. Res. Commun. 237(3):1997;645-649.
83. Shoji Y., Uedono Y., Ishikura H., Takeyama N., Tanaka T. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology. 84(4):1995;543-548.
84. Shrivastava A., Aggarwal B.B. Antioxidants differentially regulate activation of nuclear factor-κB, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-κB activation are not linked to apoptosis. Antioxid Redox Signal. 1(2):1999;181-191.
85. Sidoti-de Fraisse C., Rincheval V., Risler Y., Mignotte B., Vayssiere J.L. TNF-alpha activates at least two apoptotic signaling cascades. Oncogene. 17(13):1998;1639-1651.
86. Staal F.J., Roederer M., Herzenberg L.A., Herzenberg L.A. Intracellular thiols regulate activation of nuclear factor-κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 87(24):1990;9943-9947.
87. Strieter R.M., Kunkel S.L., Bone R.C. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit. Care Med. 21(10 Suppl.):1993;S447-63.
88. Talley A.K., Dewhurst S., Perry S.W., Dollard S.C., Gummuluru S., Fine S.M., New D., Epstein L.G., Gendelman H.E., Gelbard H.A. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the antioxidant N-acetylcysteine and the genes Bcl-2 and crmA. Mol. Cell. Biol. 15(5):1995;2359-2366.
89. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science. 274(5288):1996;787-789.
90. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., Thompson C.B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91(5):1997;627-637.
91. Wang C.Y., Cusack J.C. Jr., Liu R., Baldwin A.S. Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5(4):1999;412-417.
92. Wang C.Y., Mayo M.W., Baldwin A.S. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274(5288):1996;784-787.
93. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S. Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281(5383):1998;1680-1683.
94. Westwick J.K., Weitzel C., Minden A., Karin M., Brenner D.A. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase. J. Biol. Chem. 269(42):1994;26396-26401.
95. Wong G.H., Elwell J.H., Oberley L.W., Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58(5):1989;923-931.
96. Wong G.H., Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science. 242(4880):1988;941-944.
97. Wu H., Lozano G. NF-κB activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269(31):1994;20067-20074.
98. Xu Y., Bialik S., Jones B.E., Iimuro Y., Kitsis R.N., Srinivasan A., Brenner D.A., Czaja M.J. NF-κB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am. J. Physiol. 275(4 Pt 1):1998;C1058-1066.
99. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275(5303):1997;1129-1132.
100. Yu R., Tan T.H., Kong A.T. Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants. J. Biol. Chem. 272(46):1997;28962-28970.
101. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182(2):1995;367-377.